Author

Maud S. Jurgens

Observed names: M S Jurgens, M. Jurgens, M. S. Jurgens, M.S. Jurgens, MS Jurgens, Maud S Jurgens, Maud S. Verhoef-Jurgens

Institutions: Utrecht University, University Medical Center Utrecht

Observed institutions: Utrecht University, University Medical Center Utrecht

OpenAlex ID: A5113730040

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

2012 · M. C. van der Goes, J. W. G. Jacobs, et al. · Osteoporosis International · 61

PDF

Change of Psychological Distress and Physical Disability in Patients With Rheumatoid Arthritis Over the Last Two Decades

2013 · Cécile L. Overman, Maud S. Jurgens, et al. · Arthritis Care & Research · 42

Increase of body mass index in a tight controlled methotrexate‐based strategy with prednisone in early rheumatoid arthritis: Side effect of the prednisone or better control of disease activity?

2012 · Maud S. Jurgens, Johannes W. G. Jacobs, et al. · Arthritis Care & Research · 31

Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission.

2012 · Maud S Jurgens, Paco M J Welsing, et al. · PubMed · 26

The use of conventional disease-modifying anti-rheumatic drugs in established RA

2011 · M.S. Jurgens, J.W.G. Jacobs, et al. · Best Practice & Research Clinical Rheumatology · 23

Increased endorsement of TRIPOD and other reporting guidelines by high impact factor journals: survey of instructions to authors

2023 · Pauline Heus, Demy L. Idema, et al. · Journal of Clinical Epidemiology · 16

PDF

Contribution of the Subjective Components of the Disease Activity Score to the Response to Biologic Treatment in Rheumatoid Arthritis

2014 · Maud S. Jurgens, Cécile L. Overman, et al. · Arthritis Care & Research · 16

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial

2020 · M. S. Jurgens, M. Safy-Khan, et al. · Arthritis Research & Therapy · 12

PDF

The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials.

2014 · M S Jurgens, P M J Welsing, et al. · PubMed · 10

FRI0079 Response to mtx plus prednisone in camera ii using a multi-biomarker disease activity test (vectra™ da) and das28-esr

2013 · M.S. Jurgens, J.W. Bijlsma, et al. · Annals of the Rheumatic Diseases · 2

Alternative Ways to Quantify Sustained Remission: Applying the Continuity Rewarded Score and Patient Vector Graph

2015 · Maud S. Jurgens, Johannes W. G. Jacobs, et al. · Arthritis Care & Research · 1

PDF

FRI0024 Contribution of the Individual Components of the Disease Activity Score (DAS28) to the Total DAS28 Score among Responders and Non-Responders to Biological Therapy for Rheumatoid Arthritis

2014 · M.S. Jurgens, C.L. Overman, et al. · Annals of the Rheumatic Diseases · 1

A10.22 Response to MTX Plus Prednisone in Camera II Using a Multi-Biomarker Disease Activity (Vectra™DA) TEST and DAS28-ESR

2013 · JWJ Bijlsma, MS Jurgens, et al. · Annals of the Rheumatic Diseases · 1

PDF

AB0315 Effect of prednisone on quality of life domains in early rheumatoid arthritis - additional analyses of the camera-ii-trial -

2012 · M. Jurgens, P.M. Welsing, et al. · Annals of the Rheumatic Diseases · 1

THU0123 Is a High Contribution of Tender Joint Count and VAS General Health to the DAS28 Associated with Poor Clinical Response to Treatment in Early DMARD-Naïve RA Patients?

2015 · M. de Hair, M. Jurgens, et al. · Annals of the Rheumatic Diseases

Rheumatoid Arthritis: Aiming for Cure - Commitment to Care

2014 · M. S. Jurgens · Utrecht University Repository (Utrecht University)

SAT0051 Alternative Ways to Analyze Remission: Applying the Conrew Score and Patient Vector Graph to Camera –Trial II Data

2014 · M. Jurgens, M.C. van der Goes, et al. · Annals of the Rheumatic Diseases

AB0184 Applying the conrew score to camera -trial ii data

2013 · M.S. Jurgens, M.C. vd Goes, et al. · Annals of the Rheumatic Diseases

SAT0060 Tight Control Schedules Could be a Burden to Patients with Early RA, but they do not Negatively Impact the Improved Quality of Life Via Decreased Disease Activity - Results from the Camera Trials

2013 · M.S. Jurgens, P.M. Welsing, et al. · Annals of the Rheumatic Diseases

AB0408 Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis (CAMERA-II): Is it a side-effect of the prednisone or better control of disease activity?

2012 · M.S. Jurgens, J.W. Jacobs, et al. · Annals of the Rheumatic Diseases

AB0405 No decrease in bone mineral density when prednisone is added to a methotrexate-based tight control strategy for early rheumatoid arthritis

2012 · M.C. van der Goes, J.W. Jacobs, et al. · Annals of the Rheumatic Diseases

Works count: 21

Citation count: 243

H-index: 9

I10-index: 9